Surmodics Operating Cycle 2011-2026 | SRDX

Annual Operating Cycle Surmodics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
201	224	203	164	157	89.5	71.7	68.7	83.1	88	73.8	87.5	209	224

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
224	68.7	139

Quarterly Operating Cycle Surmodics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
207	222	226	-	205	228	187	-	208	248	250	-	104	192	187	-	151	165	181	78.8	149	164	168	67.8	156	161	144	72.2	126	139	154	72.4	147	36.8	34.4	34.5	31.4	31.8	35.9	39.3	42.9	32.9	29.5	28.3	29.7	33.1	34.3	35.1	34.9	32.5	31.2	32.4	32.4	32.4	30.1	28.8	30.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
250	28.3	105

Operating Cycle of other stocks in the Diagnostics research industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	170	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	259	$ 8.96	1.01 %	$ 597 M	USA
Aspira Women's Health AWH	73.8	-	-6.19 %	$ 10.5 M	USA
Castle Biosciences CSTL	97.9	$ 25.94	0.43 %	$ 721 M	USA
DexCom DXCM	202	$ 68.13	2.7 %	$ 26.6 B	USA
Charles River Laboratories International CRL	65	$ 154.1	1.4 %	$ 7.64 B	USA
CareDx, Inc CDNA	51.5	$ 17.47	0.87 %	$ 931 M	USA
Guardant Health GH	128	$ 88.35	1.34 %	$ 11.1 B	USA
Accelerate Diagnostics AXDX	489	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	91.7	$ 103.93	0.08 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	202	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.8 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	185	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	77.4	$ 15.57	4.11 %	$ 471 M	USA
PRA Health Sciences, Inc. PRAH	1.22 K	-	-	$ 10.7 B	USA
IQVIA Holdings IQV	73.9	$ 168.8	2.43 %	$ 29 B	USA
Biodesix BDSX	41.7	$ 17.35	0.35 %	$ 2.25 B	USA
ICON Public Limited Company ICLR	68.5	$ 99.75	2.19 %	$ 8.23 B	Irlanda
Anixa Biosciences ANIX	275	$ 2.86	0.7 %	$ 92.8 K	USA
Danaher Corporation DHR	143	$ 195.49	2.14 %	$ 139 B	USA
Biocept BIOC	134	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	177	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	216	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	198	$ 122.2	2.45 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	54.2	$ 199.41	0.23 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	172	-	-	$ 10.6 B	Niderland
Agilent Technologies A	161	$ 113.82	1.78 %	$ 34.6 B	USA
BioNano Genomics BNGO	329	$ 1.13	1.35 %	$ 1.44 M	USA
DarioHealth Corp. DRIO	251	$ 9.02	7.13 %	$ 256 M	Israel
NeoGenomics NEO	102	$ 8.31	0.85 %	$ 1.06 B	USA
Neogen Corporation NEOG	213	$ 9.26	1.59 %	$ 2.01 B	USA
Lantheus Holdings LNTH	121	$ 79.31	1.03 %	$ 5.35 B	USA
Pacific Biosciences of California PACB	244	$ 1.42	4.04 %	$ 426 M	USA
Chembio Diagnostics CEMI	164	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	405	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	50.4	$ 454.33	0.15 %	$ 13.1 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 219.09	1.66 %	$ 25.1 B	Schweiz
DermTech DMTK	114	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	29.4	$ 17.74	1.95 %	$ 397 M	USA
Invitae Corporation NVTA	368	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	206	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 200.3	1.33 %	$ 19.7 B	USA
OPKO Health OPK	285	$ 1.2	0.42 %	$ 833 M	USA